Details

Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial.

Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial. Publié dans European  Heart Journal : Acute Cardiovascular Care, le 28 avril 2015. En savoir plus en consultant le site. Auteurs : Zeymer U, Montalescot G, Ardissino D, Bolognese L, Clemmensen P, Collet JP, Lopez-Sendon…
Details

Reply: Not All NSTEMIs Are Created Equal.

Reply: Not All NSTEMIs Are Created Equal. Publié dans Journal of the American College of Cardiology, le 28 avril 2015. En savoir plus en consultant le site. Auteurs : Montalescot G, Collet JP, Ecollan P, Bolognese L, ten Berg J, Dudek D, Hamm C, Widimsky P, Tanguay JF, Goldstein P, Brown E, Miller DL, LeNarz L, Vicaut…
Details

Dual antiplatelet therapy: optimal timing, management, and duration

Dual antiplatelet therapy: optimal timing, management, and duration. Publié in European Hearth Journal - Cardiovascular Pharmacotherapy, le 23 mars 2015. En savoir plus en consultant le site. Auteurs : Pierre SABOURET, Sophie K. RUSHTON-SMITH, Mathieu KERNEIS, Johanne SILVAIN, Jean-Philippe COLLET, Gilles MONTALESCOT   Abstract Platelet activation and aggregability play a key role in the genesis of…